| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA324208
Max Phase: Preclinical
Molecular Formula: C8H17NO4
Molecular Weight: 191.23
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: CCO[C@@H]1CN[C@H](CO)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C8H17NO4/c1-2-13-6-3-9-5(4-10)7(11)8(6)12/h5-12H,2-4H2,1H3/t5-,6-,7-,8-/m1/s1
Standard InChI Key: COPXNZORHSITGP-WCTZXXKLSA-N
Associated Targets(Human)
Beta-glucocerebrosidase 14647 Activities
Associated Targets(non-human)
Alpha-mannosidase 2C1 19 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 191.23 | Molecular Weight (Monoisotopic): 191.1158 | AlogP: -1.92 | #Rotatable Bonds: 3 |
| Polar Surface Area: 81.95 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 4 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 12.96 | CX Basic pKa: 8.00 | CX LogP: -1.89 | CX LogD: -2.58 |
| Aromatic Rings: 0 | Heavy Atoms: 13 | QED Weighted: 0.42 | Np Likeness Score: 1.87 |
References
| 1. Berger A, Dax K, Gradnig G, Grassberger V, Stutz A, Ungerank M, Legler G, Bause E. (1992) Synthesis and biological activity of C-6 modified derivatives of the glucosidase inhibitor 1-deoxynojirimycin., 2 (1): [10.1016/S0960-894X(00)80648-4] |
Source
Source(1):